Filana Therapeutics (FLNA) Treasury Shares (2020)

Filana Therapeutics (FLNA) posted Treasury Shares of $800000.0 for Q3 2020, down 42.86% on a QoQ basis from $1.4 million in Q2 2020.

Analysis

Filana Therapeutics (FLNA) Treasury Shares (2020) Analysis & Trends

Filana Therapeutics has reported Treasury Shares for 1 years, with the latest figure at $800000.0 in Q3 2020.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Amgen	206.44 Bn	192.45 Bn	7.24 Bn	-
2	Gilead Sciences	179.97 Bn	176.79 Bn	6.22 Bn	-
3	Vertex Pharmaceuticals	130.57 Bn	122.72 Bn	2.84 Bn	-
4	Regeneron Pharmaceuticals	81.63 Bn	73.63 Bn	3.93 Bn	36.40 Mn
5	Argenx Se	60.34 Bn	55.16 Bn	1.37 Bn	-
6	Moderna	54.37 Bn	49.23 Bn	52.00 Mn	-
7	Alnylam Pharmaceuticals	33.07 Bn	29.76 Bn	992.69 Mn	-
8	Biogen	31.84 Bn	30.55 Bn	1.96 Bn	-23.80 Mn
9	Roivant Sciences	29.49 Bn	29.49 Bn	1.16 Mn	-
10	Filana Therapeutics	38.14 Mn	38.14 Mn	-	-

Historic Data

Download Data